ReImagine Pharma Marketing is a conference dedicated to a strategic roadmap for embedding long lasting commercial evolution across marketing in the pharmaceutical industry.
ReImagine Pharma Marketing covers topics such as:
- COVID forced acceptance of Omnichannel marketing importance: where do CX and MCM groups need to channel their energy and what elements to prioritize to deliver a consistent experience of your brand
- Digital at a critical time - identifying what the triggers for `must do` changes, and assessing if these are these connected to true long lasting digital transformation
- Video content - keeping the authenticity; examples of good stories that make for great content and pull the story forward to capture emotion
- Content consumption habits and behaviors of HCPs to develop your content and engagement strategy
- The right multichannel mix to select the right channel for the corresponding campaign
- Video content - keeping the authenticity; examples of good stories that for great content and pull the story forward to capture emotion
- A successful performance measurement framework to better interpret your data and understand your goals within analytics
- Your patient journey and adherence as a marketing aid - how `how to` and `why` build as patients continue to increase levels of expectation on access and reach
- Reimbursement: relocating reimbursement as part of the innovation process - the value proposition of tech and quantify the willingness to pay
- Data noise and digital health errors through smart use of data analytics and combining data sources
- A methodology of how to split personal and non-personal promotion
- If we have seen the promise of AI come to fruition in this current period of turbulence. Has it done the job that we thought it would?
ReImagine Pharma Marketing might be held in New Jersey, United States in May 2025.
